This highlights the novelty of the present study, which suggests that blockade of Wnt/NR2F2/GPX4 axis may serve as a novel therapeutic strategy for improving the effect of chemotherapy in lung cancer BM. The gene discussed is GPX4; the disease is lung carcinoma.